Drugs causing severe ocular surface involvements in Japanese patients with StevenseJohnson syndrome/toxic epidermal necrolysis
-
- Kaniwa Nahoko
- Division of Medicinal Safety Science, National Institute of Health Sciences
-
- Ueta Mayumi
- Department of Ophthalmology, Kyoto Prefectural University of Medicine
-
- Nakamura Ryosuke
- Division of Medicinal Safety Science, National Institute of Health Sciences
-
- Okamoto-Uchida Yoshimi
- Division of Medicinal Safety Science, National Institute of Health Sciences
-
- Sugiyama Emiko
- Division of Medicinal Safety Science, National Institute of Health Sciences
-
- Maekawa Keiko
- Division of Medicinal Safety Science, National Institute of Health Sciences
-
- Takahashi Yukitoshi
- Shizuoka Institute of Epilepsy and Neurological Disorders
-
- Furuya Hirokazu
- Department of Neurology, Kochi Medical School
-
- Yagami Akiko
- Department of Dermatology, School of Medicine, Fujita Health University
-
- Matsukura Setsuko
- Department of Environmental Immuno-Dermatology, Graduate School of Medicine, Yokohama City University
-
- Ikezawa Zenro
- Department of Environmental Immuno-Dermatology, Graduate School of Medicine, Yokohama City University
-
- Matsunaga Kayoko
- Department of Dermatology, School of Medicine, Fujita Health University
-
- Sotozono Chie
- Department of Ophthalmology, Kyoto Prefectural University of Medicine
-
- Aihara Michiko
- Department of Environmental Immuno-Dermatology, Graduate School of Medicine, Yokohama City University
-
- Kinoshita Shigeru
- Department of Ophthalmology, Kyoto Prefectural University of Medicine
-
- Saito Yoshiro
- Division of Medicinal Safety Science, National Institute of Health Sciences
Bibliographic Information
- Other Title
-
- Drugs causing severe ocular surface involvements in Japanese patients with Stevens–Johnson syndrome/toxic epidermal necrolysis
Search this article
Journal
-
- Allergology International
-
Allergology International 64 (4), 379-381, 2015
Japanese Society of Allergology
